4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:动物毒液多肽毒素
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > acid_base_buffer_solution > Smartox/钾通道阻滞剂/08TER001-00500/0.5mg
商品详细Smartox/钾通道阻滞剂/08TER001-00500/0.5mg
Smartox/钾通道阻滞剂/08TER001-00500/0.5mg
Smartox/钾通道阻滞剂/08TER001-00500/0.5mg
商品编号: 08TER001-00500
品牌: smartox-biotech
市场价: ¥3120.00
美元价: 2400.00
产地: 美国(厂家直采)
公司:
产品分类: 酸碱缓冲液
公司分类: acid_base_buffer_solution
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

Tertiapin hasbeenisolatedfromthevenomoftheHoneybee ApismelliferaTertiapin-Q isanoxidation-resistantmutantofthewild-typetertiapinwhereMethionine13hasbeenreplacedbyaGlutamine. Tertiapin-Q blockstheinwardlyrectifying Kir1.1(ROMK1) and Kir3.1/3.4(GIRK1/GIRK4alsoknownasIKACh) potassiumchannelswithKdvaluesofaround2nMand8nMrespectively.Tertiapin-Q alsoinhibitscalcium-activatedlargeconductance BKpotassiumchannels (KCa1.1)inaconcentrationandvoltage-dependentmanner(IC50 ~5nM),inadditiontoinhibiting Kir3.1/3.2(GIRK1/GIRK2) heteromultimerpotassiumchannelswithaKdcloseto270nM. Tertiapin-Q canpreventdose-dependentacetylcholine(ACh)-inducedatrioventricularblocksinmammalianhearts,asKCNJ3/KCNJ5channels(alsonamedI(KACh)),areactivatedbyAChfoundinmammalianmyocytes.


Description:

Productcode:N/A.Categories:Inwardlyrectifyingpotassiumchannels,Potassiumchannels.Tags:252198-49-5,inward,kir.

AAsequence: Ala-Leu-Cys3-Asn-Cys5-Asn-Arg-Ile-Ile-Ile-Pro-His-Gln-Cys14-Trp-Lys-Lys-Cys18-Gly-Lys-Lys-NH2
Disulfidebonds: Cys3-Cys14 andCys5-Cys18
Length(aa): 21
Formula: C106H175N35O24S4
MolecularWeight: 2452Da
Appearance:Whitelyophilizedsolid
Solubility: waterandsalinebuffer
CASnumber: [252198-49-5]Source: Synthetic
Purityrate: >97%

Reference:

CharacterizationofKir1.1channelswiththeuseofarADIolabeledderivativeoftertiapin,Biochemistry

Inwardrectifierpotassium channels (Kir)playcriticalrolesincellphysiology.Despiterepresentingthesimplesttetramericpotassiumchannelstructures,thepharmacologyofthischannelfamilyremainslargelyundeveloped.Inthisrespect, tertiapin (TPN),a21aminoacidpeptideisolatedfrombeevenom,hasbeenreportedtoinhibit Kir1.1 andKir3.1/3.4 channels withhighaffinitybybindingtotheM1-M2linkerregionofthese channels.Thefeaturesofthepeptide-channelinteractionhavebeenexploredelectrophysiologically,&thesestudieshaveidentifiedwaysbywhichtoalterthecompositionofthepeptidewithoutaffectingitsBIOLOGicalactivity.Inthepresentstudy,theTPN derivative,TPN-Y1/K12/Q13,hasbeensynthesized&radiolabeled tohighspecificactivitywith(125)I.TPN-Y1/K12/Q13&mono-iodo-TPN-Y1/K12/Q13([(127)I]TPN-Y1/K12/Q13)inhibitwithhighaffinityratbutnothuman Kir1.1 channels stablyexpressedinHEK293cells.[(125)I]TPN-Y1/K12/Q13bindsinasaturable,time-dependent,&reversIBLemannertoHEK293cellsexpressingrat Kir1.1,aswellastomembranesderivedfromthesecells,&thepharmacologyofthebindingreactionisconsistentwithpeptidebindingto Kir1.1 channels.Studiesusingchimeric channels indicatethatthedifferencesinTPNsensitivitybetweenrat&human Kir1.1 channels areduetothepresenceoftwononconservedresidueswithintheM1-M2linkerregion.Whentheseresultsaretakentogether,theydemonstratethat[(125)I]TPN-Y1/K12/Q13representsthefirsthighspecificactivityradioligandforstudyingrat Kir1.1 channels&suggestitsutilityforidentifyingotherKirchannelmodulators.

Felix,J.P.,etal.(2006)CharacterizationofKir1.1channelswiththeuseofaradiolabeledderivativeoftertiapin,Biochemistry. PMID: 16906771

Tertiapin-QblocksrecombinantandnativelargeconductanceK+channelsinause-dependentmanner

Tertiapin,ashortpeptidefromhoneybeevenom,hasbeenreportedtospecificallyblocktheinwardlyrectifying K(+)(Kir) channels,includingGprotein-coupledinwardlyrectifyingpotassiumchannel(GIRK)1+GIRK4heteromultimers&ROMK1homomultimers.Inthepresentstudy,theeffectsofastable&functionallysimilarderivativeoftertiapin, tertiapin-Q,wereexaminedon recombinant humanvoltage-dependentCa(2+)-activated largeconductance K(+)channel(BKorMaxiK;alpha-subunitorhSlo1homomultimers)&mouseinwardlyrectifyingGIRK1+GIRK2(i.e.,Kir3.1&Kir3.2)heteromultimeric K(+) channels expressedinXenopusoocytes&inculturednewbornmousedorsalrootganglion(DRG)neurons.Intwo-electrodevoltage-clampedoocytes, tertiapin-Q (1-100nM)inhibitedBK-type K(+) channels inause-&concentration-dependent manner.Wealsoconfirmedtheinhibitionof recombinant GIRK1+GIRK2heteromultimersby tertiapin-Q,whichhadnoeffectonendogenousdepolarization-&hyperpolarization-activatedcurrentssensitivetoextracellulardivalentcations(Ca(2+),Mg(2+),Zn(2+),&Ba(2+))indefolliculatedoocytes.Involtage-clampedDRGneurons, tertiapin-Q voltage-&use-dependentlyinhibitedoutwardlyrectifying K(+)currents,butCs(+)-blockedhyperpolarization-activatedinwardcurrentsincludingI(H)wereinsensitiveto tertiapin-Q,baclofen,barium,&zinc,suggestingabsenceoffunctionalGIRK channels inthenewborn.Undercurrent-clampconditions, tertiapin-Q blockedtheactionpotentialafterhyperpolarization(AHP)&increasedactionpotentialdurationinDRGneurons.Takentogether,theseresultsdemonstratethattheblockingactionsof tertiapin-Q arenotspecifictoKir channels&thattheblockadeofrecombinant BK channels&native neuronalAHPcurrentsis use-dependent.InhibitionofspecifictypesofKir&voltage-dependentCa(2+)-activated K(+) channels by tertiapin-Q atnanomolarrangeviadifferentmechanismsmayhaveimplicationsinpainphysiology&therapy.

Kanjhan,R.,C etal.(2005)Tertiapin-QblocksrecombinantandnativelargeconductanceK+channelsinause-dependentmanner, JPharmacolExpTher. PMID: 15947038

Titrationoftertiapin-QinhibitionofROMK1channelsbyextracellularprotons

Tertiapin-Q (TPN(Q)),ahoneybeetoxinderivative,inhibitsinward-rectifierK(+) channels bybindingtotheirexternalvestibule.InthepresentstudywefoundthatTPN(Q) inhibition ofthe channels isprofoundlyaffectedby extracellular pH.ThispHdependencemainlyreflects titration ofhistidineresidue12inTPN(Q)by extracellular protons,sinceitlargelyvanisheswhenthehistidineresidueisreplacedwithalanine.Notsurprisingly,thisalaninederivativeofTPN(Q)bindstothechannelwithmuchloweraffinity.QuantitativeThermodynamiccycleanalysisshowsthatdeprotonationofthehistidineresiduereducestheTPN(Q)-ROMK1 bindingenergyby1.6kcal/mol.ToeliminatepHsensitivitybutretainhighaffinity,wederivatizedTPN(Q)byreplacinghistidine12withlysine.Thisderivative-denotedtertiapin-KQ(TPN(KQ))-notonlyispracticallyinsensitiveto extracellular pHbutalsobindstothechannelwithevenhigheraffinitythanTPN(Q)at extracellular pH7.6.

Ramu,Y., etal.(2001)Titrationoftertiapin-QinhibitionofROMK1channelsbyextracellularprotons, Biochemistry. PMID: 11297426

TertiapinpotentlyandselectivelyblocksmuscarinicK(+)channelsinrabbitcardiacmyocytes

Tertiapin isa21-residuepeptideisolatedfromhoneybeevenoms.Arecentstudyindicatedthat tertiapin isapotentblockerofcertaintypesofinwardlyrectifying K(+)(Kir) channels ().Weexaminedtheeffectof tertiapin onionchannelcurrentsin rabbit cardiac myocytes usingthepatch-clamptechnique.Inthewhole-cellconfiguration, tertiapin fullyinhibitedacetylcholine(1microM)-induced muscarinic K(+)(K(ACh))channelcurrentsinatrialmyocytes withthehalf-maximuminhibitoryconcentrationofapproximately8nMthroughapproximately1:1stoichiometry.Thepotencyof tertiapin ininhibiting K(ACh) channels wasnotsignificantlydifferentat-40&-100mV. Tertiapin alsoinhibitedthe K(ACh)channelpreactivatedbyintracellularguanosine5′-O-(3-thiotriphosphate),anonhydrolyzableGTPanalog.AconstitutivelyactiveKirchannel,theI(K1)channel,wasatleast100timeslesssensitiveto tertiapin.AnotherKirchannelin cardiac myocytes,theATP-sensitive K(+)channel,wasvirtuallyinsensitiveto tertiapin (1microM).Thevoltage-dependent K(+)&theL-typeCa(2+) channels werenotaffectedby tertiapin (1microM).Atthesingle-channellevel, tertiapin inhibitedtheK(ACh)channelfromtheoutsideofthemembranebyreducingtheNP(o)(Nisthenumberoffunctional channels,&theP(o)istheopenprobABIlityofeachchannel)withoutaffectingthesingle-channelconductanceorfastkinetics.Therefore, tertiapin potently&selectively blocks the K(ACh)channelin cardiac myocytes inareceptor-&voltage-independentmanner. Tertiapin isanovelpharmacologicaltooltoidentifythefunctionalroleofthe K(ACh)channelintheparasympatheticregulationoftheheartbeat.

Kitamura,H., etal.(2000)TertiapinpotentlyandselectivelyblocksmuscarinicK(+)channelsinrabbitcardiacmyocytes, JPharmacolExpTher. PMID: 10734170

Mechanismsofinward-rectifierK+channelinhibitionbytertiapin-Q,Biochemistry

Tertiapin-Q(TPN(Q))isaderivativeofhoneybeetoxintertiapin(TPN)whosemethionineresidueisreplacedwithaglutamineresidue.TPN(Q)inhibitstheROMK1&GIRK1/4inward-rectifierK(+)channelswithaffinitiesverysimilartoTPN.However,unlikenativeTPN,TPN(Q)isnonoxidizablebyair.ThestabilityofTPN(Q)allowsustoinvestigatehowitinteractswiththetargetedchannels.WefoundthattheinteractionbetweenTPN(Q)&theROMK1channelisabimolecularreaction,i.e.,oneTPN(Q)moleculebindstoonechannel.TheinteractionsurfaceinTPN(Q)isprimarilyformedbyitsalphahelixratherthanthebetasheetswithwhichscorpiontoxinsformtheirinteractionsurface.Themutagenesisstudiesonboththechannel&TPN(Q)togetherstronglysuggestthattoblocktheK(+)poreTPN(Q)plugsitsalphahelixintothevestibuleoftheK(+)pore,whileleavingtheextendedstructuralportionstickingoutofthevestibuleintotheextracellularmedia.

Jin,W., etal.(1999)Mechanismsofinward-rectifierK+channelinhibitionbytertiapin-Q, Biochemistry. PMID: 10572004

Synthesisofastableformoftertiapin:ahigh-affinityinhibitorforinward-rectifierK+channels

Tertiapin (TPN),asmallproteinderivedfromhoneybeevenom,inhibitstheGIRK1/4&ROMK1 channels withnanomolaraffinities.Methionineresidue13inTPNinteractswithresidueF148inthechannel,locatedjustoutsideofthenarrowregionoftheROMK1pore.ThemethionineresidueinTPNcanbeoxidizedbyair,whichsignificantlyhindersTPNbindingtothe channels.ToovercomethereductioninTPNaffinityduetooxidationofM13,wereplacedM13inTPNwithfourteendifferentresidues.Outofthefourteenderivatives,onlytheoneinwhichM13wasreplacedbyglutamine,TPNQ,bindstothechannelwithaKivalueverysimilartothatofnativeTPN.SinceTPNQis stable&functionallyresemblesnativeTPN,itwillbeaveryusefulmolecularprobeforstudyingthe inward-rectifier K+ channels.

Jin,W.,andLu,Z.(1999)Synthesisofastableformoftertiapin:ahigh-affinityinhibitorforinward-rectifierK+channels, Biochemistry. PMID: 10572003

品牌介绍
Smartox Biotechnology 是全球唯一一家专门生产动物毒液多肽毒素,用于细胞离子通道功能研究的生物医药公司。多肽毒素在生物制药领域具有重要的使用价值。Smartox Biotechnology 于 2009 年由来自 Grenoble 神经科学研究所 (Grenoble Institute of Neuroscience) 的 Michel de waard 博士创立, Smartox Biotechnology 专门研究动物毒液,制作合成多种毒液中的多肽成分(常称为毒素)。 De Waard 博士研究离子通道与毒素多肽的关系,尤其是鉴定、开发毒素多肽作为治疗性分子或细胞穿透肽 (cell penetrating peptides, CPP) 。其研究团队在毒液分离,药理性活性肽鉴定、富半胱氨酸肽定性、制作和优化等方面具有独特、丰富的经验。 2010 年, Smartox Biotechnolgy 被法国研究部 (Ministry of Research) 授予“新兴企业 OSEO 奖 (OSEO prize for emerging businesses) ”。